Zhong Guo Jing Ji Wang·2025-12-13 07:03Core Viewpoint - Yuntian Lifei (688343.SH) reported significant revenue growth for the first three quarters of 2025, with a revenue of 9.51 billion yuan, marking a year-on-year increase of 96.85%. However, the company continues to face net losses, although the losses have decreased compared to the previous year [1][4]. Financial Performance - For the period of January to September 2025, the company achieved an operating revenue of 9.51 billion yuan, which is a 96.85% increase compared to the same period last year [1]. - The net profit attributable to shareholders was -2.98 billion yuan, an improvement from -4.25 billion yuan in the same period last year [1]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -3.41 billion yuan, compared to -5.00 billion yuan in the previous year [1]. - The net cash flow from operating activities was 1.95 billion yuan [1]. Historical Performance - From 2017 to 2024, the net profit attributable to shareholders has shown a trend of increasing losses, with figures of -54.64 million yuan in 2017, -1.95 billion yuan in 2018, and reaching -5.79 billion yuan in 2024 [4]. - The net profit after deducting non-recurring gains and losses has also increased from -64.56 million yuan in 2017 to -6.84 billion yuan in 2024 [4]. Stock Market Activity - Yuntian Lifei was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on April 4, 2023, with an initial public offering of 88.78 million shares at a price of 43.92 yuan per share [3]. - The company raised a total of 389.94 million yuan, with a net amount of 358.35 million yuan after deducting issuance costs, exceeding the original fundraising plan by 58.35 million yuan [3].